Ledger.Open graph →
SEC Form D · filed November 4, 2022

nference, inc

Offering
$2.7M
Sold
$2.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Murali Aravamudan · Cambridge, MAExec · DirectorAjit Rajasekharan · Cambridge, MAExecDavid Goel · Cambridge, MADirectorVenkataramanan Soundararajan · Cambridge, MAExecThomas Mcnaughton · HOLLISTON, MAExecJeff Richards · New York, NYDirectorRyan Denehy · New York, NYExecDavid Darst · New York, NYExec · DirectorMasoud Tavazoie · New York, NYExecJohn Halamka · Cambridge, MADirectorAnand K. Chari · Itasca, ILExec · DirectorMichael J. Small · Itasca, ILExecJean B. Dekernion · Los Angeles, CADirectorLouis L. Gonda · Los Angeles, CAExecThomas Mcnaughton · Cambridge, MAExecJohn Halamka · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗